Agricultural Inputs
Compare Stocks
5 / 10Stock Comparison
AVD vs REZI vs JCI vs MFIN vs HON
Revenue, margins, valuation, and 5-year total return — side by side.
Security & Protection Services
Construction
Financial - Credit Services
Conglomerates
AVD vs REZI vs JCI vs MFIN vs HON — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Agricultural Inputs | Security & Protection Services | Construction | Financial - Credit Services | Conglomerates |
| Market Cap | $87M | $5.96B | $85.12B | $227M | $135.04B |
| Revenue (TTM) | $523M | $7.47B | $24.43B | $353M | $36.76B |
| Net Income (TTM) | $-46M | $-527M | $3.53B | $47M | $4.10B |
| Gross Margin | 29.8% | 29.4% | 36.6% | 96.7% | 36.9% |
| Operating Margin | 1.5% | 8.1% | 13.6% | 50.5% | 14.9% |
| Forward P/E | 8.0x | 12.9x | 28.8x | 8.7x | 20.2x |
| Total Debt | $191M | $3.17B | $11.19B | $316M | $34.58B |
| Cash & Equiv. | $12M | $661M | $379M | $202M | $12.49B |
AVD vs REZI vs JCI vs MFIN vs HON — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| American Vanguard C… (AVD) | 100 | 22.9 | -77.1% |
| Resideo Technologie… (REZI) | 100 | 563.0 | +463.0% |
| Johnson Controls In… (JCI) | 100 | 444.2 | +344.2% |
| Medallion Financial… (MFIN) | 100 | 414.6 | +314.6% |
| Honeywell Internati… (HON) | 100 | 146.1 | +46.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AVD vs REZI vs JCI vs MFIN vs HON
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AVD ranks third and is worth considering specifically for value.
- Lower P/E (8.0x vs 20.2x)
REZI is the clearest fit if your priority is momentum.
- +98.3% vs AVD's -30.8%
JCI has the current edge in this matchup, primarily because of its strength in long-term compounding and valuation efficiency.
- 344.1% 10Y total return vs HON's 132.4%
- PEG 1.12 vs HON's 11.03
- 14.5% margin vs AVD's -8.7%
- 9.0% ROA vs AVD's -7.1%, ROIC 8.5% vs 2.7%
MFIN is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 21.1%, EPS growth 17.1%
- Lower volatility, beta 1.14, Low D/E 62.3%, current ratio 27.10x
- Beta 1.14, yield 4.7%, current ratio 27.10x
- 21.1% NII/revenue growth vs AVD's -5.9%
HON is the clearest fit if your priority is income & stability.
- Dividend streak 15 yrs, beta 0.74, yield 2.2%
- Beta 0.74 vs REZI's 2.24
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 21.1% NII/revenue growth vs AVD's -5.9% | |
| Value | Lower P/E (8.0x vs 20.2x) | |
| Quality / Margins | 14.5% margin vs AVD's -8.7% | |
| Stability / Safety | Beta 0.74 vs REZI's 2.24 | |
| Dividends | 4.7% yield, 4-year raise streak, vs HON's 2.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +98.3% vs AVD's -30.8% | |
| Efficiency (ROA) | 9.0% ROA vs AVD's -7.1%, ROIC 8.5% vs 2.7% |
AVD vs REZI vs JCI vs MFIN vs HON — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
AVD vs REZI vs JCI vs MFIN vs HON — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MFIN leads in 2 of 6 categories
AVD leads 1 • REZI leads 0 • JCI leads 0 • HON leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MFIN leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 104.1x MFIN's $353M. JCI is the more profitable business, keeping 14.5% of every revenue dollar as net income compared to AVD's -8.7%. On growth, JCI holds the edge at +8.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $523M | $7.5B | $24.4B | $353M | $36.8B |
| EBITDAEarnings before interest/tax | $22M | $802M | $3.9B | $111M | $6.5B |
| Net IncomeAfter-tax profit | -$46M | -$527M | $3.5B | $47M | $4.1B |
| Free Cash FlowCash after capex | -$41M | -$1.3B | $1.4B | $126M | $4.2B |
| Gross MarginGross profit ÷ Revenue | +29.8% | +29.4% | +36.6% | +96.7% | +36.9% |
| Operating MarginEBIT ÷ Revenue | +1.5% | +8.1% | +13.6% | +50.5% | +14.9% |
| Net MarginNet income ÷ Revenue | -8.7% | -7.1% | +14.5% | +12.2% | +11.2% |
| FCF MarginFCF ÷ Revenue | -7.8% | -16.8% | +5.7% | +35.7% | +11.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.7% | +2.0% | +8.2% | — | -6.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +53.3% | +11.4% | +38.9% | +16.3% | -41.9% |
Valuation Metrics
AVD leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 5.4x trailing earnings, MFIN trades at a 90% valuation discount to JCI's 53.0x P/E. Adjusting for growth (PEG ratio), JCI offers better value at 2.07x vs HON's 15.77x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $87M | $6.0B | $85.1B | $227M | $135.0B |
| Enterprise ValueMkt cap + debt − cash | $266M | $8.5B | $95.9B | $342M | $157.1B |
| Trailing P/EPrice ÷ TTM EPS | -1.74x | -10.54x | 53.05x | 5.43x | 28.96x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.00x | 12.91x | 28.76x | 8.66x | 20.24x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.07x | — | 15.77x |
| EV / EBITDAEnterprise value multiple | 8.18x | 10.55x | 25.98x | 1.92x | 19.75x |
| Price / SalesMarket cap ÷ Revenue | 0.17x | 0.80x | 3.61x | 0.64x | 3.61x |
| Price / BookPrice ÷ Book value/share | 0.45x | 2.03x | 7.04x | 0.46x | 8.87x |
| Price / FCFMarket cap ÷ FCF | — | — | 88.21x | 1.80x | 25.04x |
Profitability & Efficiency
MFIN leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JCI delivers a 24.9% return on equity — every $100 of shareholder capital generates $25 in annual profit, vs $-22 for AVD. MFIN carries lower financial leverage with a 0.62x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), MFIN scores 7/9 vs REZI's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -21.9% | -18.1% | +24.9% | +9.4% | +23.1% |
| ROA (TTM)Return on assets | -7.1% | -6.2% | +9.0% | +1.6% | +5.3% |
| ROICReturn on invested capital | +2.7% | +9.0% | +8.5% | +17.2% | +12.6% |
| ROCEReturn on capital employed | +3.5% | +9.3% | +9.8% | +10.0% | +12.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 6 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.99x | 1.09x | 0.86x | 0.62x | 2.24x |
| Net DebtTotal debt minus cash | $179M | $2.5B | $10.8B | $115M | $22.1B |
| Cash & Equiv.Liquid assets | $12M | $661M | $379M | $202M | $12.5B |
| Total DebtShort + long-term debt | $191M | $3.2B | $11.2B | $316M | $34.6B |
| Interest CoverageEBIT ÷ Interest expense | -3.54x | -2.36x | 18.41x | 1.07x | 3.92x |
Total Returns (Dividends Reinvested)
Evenly matched — REZI and JCI each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JCI five years ago would be worth $22,283 today (with dividends reinvested), compared to $1,729 for AVD. Over the past 12 months, REZI leads with a +98.3% total return vs AVD's -30.8%. The 3-year compound annual growth rate (CAGR) favors REZI at 34.3% vs AVD's -44.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -20.2% | +13.1% | +14.4% | -3.9% | +9.4% |
| 1-Year ReturnPast 12 months | -30.8% | +98.3% | +54.6% | +10.2% | +1.5% |
| 3-Year ReturnCumulative with dividends | -82.7% | +142.4% | +128.3% | +60.4% | +14.7% |
| 5-Year ReturnCumulative with dividends | -82.7% | +39.1% | +122.8% | +24.8% | +1.0% |
| 10-Year ReturnCumulative with dividends | -71.4% | +37.1% | +344.1% | +61.7% | +132.4% |
| CAGR (3Y)Annualised 3-year return | -44.3% | +34.3% | +31.7% | +17.1% | +4.7% |
Risk & Volatility
Evenly matched — JCI and HON each lead in 1 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than REZI's 2.24 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JCI currently trades 94.7% from its 52-week high vs AVD's 51.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.22x | 2.24x | 0.95x | 1.14x | 0.74x |
| 52-Week HighHighest price in past year | $5.92 | $45.29 | $147.32 | $11.00 | $248.18 |
| 52-Week LowLowest price in past year | $2.05 | $19.34 | $90.35 | $7.88 | $186.76 |
| % of 52W HighCurrent price vs 52-week peak | +51.4% | +87.8% | +94.7% | +87.8% | +85.9% |
| RSI (14)Momentum oscillator 0–100 | 54.3 | 56.4 | 47.5 | 58.2 | 44.2 |
| Avg Volume (50D)Average daily shares traded | 367K | 1.1M | 3.3M | 59K | 3.7M |
Analyst Outlook
Evenly matched — MFIN and HON each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AVD as "Buy", REZI as "Buy", JCI as "Buy", MFIN as "Hold", HON as "Buy". Consensus price targets imply 459.2% upside for AVD (target: $17) vs 0.6% for REZI (target: $40). For income investors, MFIN offers the higher dividend yield at 4.68% vs REZI's 0.59%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $17.00 | $40.00 | $143.14 | — | $243.83 |
| # AnalystsCovering analysts | 13 | 7 | 45 | 9 | 28 |
| Dividend YieldAnnual dividend ÷ price | — | +0.6% | +1.1% | +4.7% | +2.2% |
| Dividend StreakConsecutive years of raises | 0 | 2 | 5 | 4 | 15 |
| Dividend / ShareAnnual DPS | — | $0.23 | $1.49 | $0.45 | $4.63 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +7.0% | +0.4% | +2.8% |
MFIN leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AVD leads in 1 (Valuation Metrics). 3 tied.
AVD vs REZI vs JCI vs MFIN vs HON: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AVD or REZI or JCI or MFIN or HON a better buy right now?
For growth investors, Medallion Financial Corp.
(MFIN) is the stronger pick with 21. 1% revenue growth year-over-year, versus -5. 9% for American Vanguard Corporation (AVD). Medallion Financial Corp. (MFIN) offers the better valuation at 5. 4x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate American Vanguard Corporation (AVD) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AVD or REZI or JCI or MFIN or HON?
On trailing P/E, Medallion Financial Corp.
(MFIN) is the cheapest at 5. 4x versus Johnson Controls International plc at 53. 0x. On forward P/E, American Vanguard Corporation is actually cheaper at 8. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Johnson Controls International plc wins at 1. 12x versus Honeywell International Inc. 's 11. 03x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — AVD or REZI or JCI or MFIN or HON?
Over the past 5 years, Johnson Controls International plc (JCI) delivered a total return of +122.
8%, compared to -82. 7% for American Vanguard Corporation (AVD). Over 10 years, the gap is even starker: JCI returned +344. 1% versus AVD's -71. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AVD or REZI or JCI or MFIN or HON?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Resideo Technologies, Inc. 's 2. 24β — meaning REZI is approximately 201% more volatile than HON relative to the S&P 500. On balance sheet safety, Medallion Financial Corp. (MFIN) carries a lower debt/equity ratio of 62% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AVD or REZI or JCI or MFIN or HON?
By revenue growth (latest reported year), Medallion Financial Corp.
(MFIN) is pulling ahead at 21. 1% versus -5. 9% for American Vanguard Corporation (AVD). On earnings-per-share growth, the picture is similar: American Vanguard Corporation grew EPS 61. 1% year-over-year, compared to -718. 0% for Resideo Technologies, Inc.. Over a 3-year CAGR, REZI leads at 5. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AVD or REZI or JCI or MFIN or HON?
Johnson Controls International plc (JCI) is the more profitable company, earning 13.
9% net margin versus -9. 7% for American Vanguard Corporation — meaning it keeps 13. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MFIN leads at 50. 5% versus 2. 7% for AVD. At the gross margin level — before operating expenses — MFIN leads at 96. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AVD or REZI or JCI or MFIN or HON more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Johnson Controls International plc (JCI) is the more undervalued stock at a PEG of 1. 12x versus Honeywell International Inc. 's 11. 03x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, American Vanguard Corporation (AVD) trades at 8. 0x forward P/E versus 28. 8x for Johnson Controls International plc — 20. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVD: 459. 2% to $17. 00.
08Which pays a better dividend — AVD or REZI or JCI or MFIN or HON?
In this comparison, MFIN (4.
7% yield), HON (2. 2% yield), JCI (1. 1% yield), REZI (0. 6% yield) pay a dividend. AVD does not pay a meaningful dividend and should not be held primarily for income.
09Is AVD or REZI or JCI or MFIN or HON better for a retirement portfolio?
For long-horizon retirement investors, Honeywell International Inc.
(HON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), 2. 2% yield, +132. 4% 10Y return). Resideo Technologies, Inc. (REZI) carries a higher beta of 2. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HON: +132. 4%, REZI: +37. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AVD and REZI and JCI and MFIN and HON?
These companies operate in different sectors (AVD (Basic Materials) and REZI (Industrials) and JCI (Industrials) and MFIN (Financial Services) and HON (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AVD is a small-cap quality compounder stock; REZI is a small-cap quality compounder stock; JCI is a mid-cap quality compounder stock; MFIN is a small-cap high-growth stock; HON is a mid-cap quality compounder stock. REZI, JCI, MFIN, HON pay a dividend while AVD does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.